Home › Atrial Fibrillation › NCT01258231

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Who can join

Ages 20 to 90 · All sexes

Inclusion Criteria:

* Undergoing heart surgery
* Willing to provide consent

Exclusion Criteria:

* Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

About the study

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Sponsor: Brigham and Women's Hospital · Participants: 4,000 · Started: 2000-08

Contact the study team

Official record on ClinicalTrials.gov — NCT01258231

Locations in the U.S.

Conditions

• Atrial Fibrillation
• Heart Attack
• Heart Failure

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.